VAERS reports by lot

GSK DTaP/Tdap lot Y4259: VAERS reports

43 VAERS reports list lot Y4259 as a GSK DTaP/Tdap vaccine, received between 2022-08-03 and 2024-03-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
0%
Marked serious
0
With a death outcome
19
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction542%
General / Systemic (non-local)325%
Allergic / Anaphylactic217%
Neurological18%
Dermatological (non-injection-site)18%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois6
Michigan6
Texas4
Nebraska3
Pennsylvania3
Iowa2
Georgia2
Idaho2
Florida2
Utah1
Minnesota1
Colorado1

Reports by month received

2022-082
2022-093
2022-101
2022-114
2022-122
2023-012
2023-024
2023-031
2023-052
2023-061
2023-071
2023-081
2023-091
2023-101
2023-111
2023-121
2024-011
2024-022
2024-0312

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.